DELFI DIAGNOSTICS

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2022–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	6	2
2025	—	8	2
2024	—	5	2
2023	—	8	2
2022	—	9	2

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
W STRATEGIES, LLC	—	20
TODD STRATEGY GROUP	—	7
TIBER CREEK GROUP	—	9

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	24
SENATE	19
Centers For Medicare and Medicaid Services (CMS)	2
Health & Human Services, Dept of (HHS)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	20
Health Issues	Health Issues	16
Trade (domestic/foreign)	Trade (domestic/foreign)	1
Pharmacy	Pharmacy	1

Bills Explicitly Cited (17)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2026 · third_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2026 · second_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2026 · second_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2026 · first_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.1406

Show 13 more cited filings

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2026 · first_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2025 · fourth_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2025 · fourth_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2025 · second_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2025 · third_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2025 · third_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2025 · second_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.1406

H.R. 1406119th Congress

Lung Cancer Screening and Prevention Act of 2025

2025 · first_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.1406

H.R. 6693118th Congress

Lung Cancer Screening and Prevention Act of 2023

2024 · fourth_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.6693

H.R. 6693118th Congress

Lung Cancer Screening and Prevention Act of 2023

2024 · third_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.6693

H.R. 6693118th Congress

Lung Cancer Screening and Prevention Act of 2023

2024 · second_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R.6693

H.R. 6693118th Congress

Lung Cancer Screening and Prevention Act of 2023

2024 · first_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $40,000

Matched citations: H.R.6693

H.R. 6693118th Congress

Lung Cancer Screening and Prevention Act of 2023

2023 · fourth_quarter · Firm: W STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $50,000

Matched citations: H.R.6693

Source: Senate LDA

DELFI DIAGNOSTICS — Lobbying Disclosure | Poliscope